Literature DB >> 30545259

Vascular Injury Is a Major Cause of Lung Injury After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Kentaro Ejiri1,2, Aiko Ogawa3, Shinya Fujii1, Hiroshi Ito2, Hiromi Matsubara1,3.   

Abstract

BACKGROUND: Balloon pulmonary angioplasty (BPA) has become an alternative treatment for inoperable patients with chronic thromboembolic pulmonary hypertension. Lung injury (LI) is a major complication of BPA and may attenuate the benefits of BPA. Therefore, we conducted a retrospective study to evaluate the association between patient and procedural characteristics and LI in patients with chronic thromboembolic pulmonary hypertension. METHODS AND
RESULTS: We reviewed 76 patients with chronic thromboembolic pulmonary hypertension who underwent BPA and multidetector computed tomography scanning pre- and post-BPA procedures. We performed BPA on 1247 vessels during 297 BPA procedures and reviewed 594 multidetector computed tomography scans. By comparing pre- and post-BPA multidetector computed tomography images, we diagnosed LI as follows: newly appeared ground-glass opacity, consolidation, and pleural effusion. LI was detected using multidetector computed tomography scans during 138 procedures (47%), and mechanical ventilation was required during 40 procedures (13%). Angiographic findings of extravasation with or without simultaneous clinical symptoms (BPA-related vascular injury) occurred during 50 procedures (17%). In mixed-effect logistic regression models, the BPA-related vascular injury was an independent predictor of LI after BPA, odds ratio, 20.1 (6.43-63.1). High mean pulmonary artery pressure before BPA procedure and BPA-related vascular injury were independent predictors of mechanical ventilation after BPA, odds ratio, 1.13 (1.03-1.24) and 10.8 (3.77-30.9), respectively.
CONCLUSIONS: Vascular injury during BPA could be a triggering factor of LI after BPA, and its severity could be exacerbated by a high pulmonary artery pressure.

Entities:  

Keywords:  angiography; hypertension; lung injury; pleural effusion; pulmonary; pulmonary artery

Mesh:

Year:  2018        PMID: 30545259     DOI: 10.1161/CIRCINTERVENTIONS.117.005884

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  10 in total

Review 1.  Chronic Thromboembolic Pulmonary Hypertension: the Bedside.

Authors:  Yuri Matusov; Inderjit Singh; Yen-Rei Yu; Hyung J Chun; Bradley A Maron; Victor F Tapson; Michael I Lewis; Sudarshan Rajagopal
Journal:  Curr Cardiol Rep       Date:  2021-08-19       Impact factor: 2.931

Review 2.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Amanda Lloji; Urvashi Hooda; Jayakumar Sreenivasan; Ramin Malekan; Wilbert S Aronow; Gregg M Lanier
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15

3.  Systematic Staged Percutaneous Balloon Pulmonary Angioplasty in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Kazuhiro Dan; Akira Shionoda; Hiromi Matsubara
Journal:  Arq Bras Cardiol       Date:  2021-02       Impact factor: 2.000

Review 4.  Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Ehtisham Mahmud; Mitul Patel; Lawrence Ang; David Poch
Journal:  Pulm Circ       Date:  2021-05-24       Impact factor: 3.017

5.  French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Philippe Brenot; Xavier Jaïs; Yu Taniguchi; Carlos Garcia Alonso; Benoit Gerardin; Sacha Mussot; Olaf Mercier; Dominique Fabre; Florence Parent; Mitja Jevnikar; David Montani; Laurent Savale; Olivier Sitbon; Elie Fadel; Marc Humbert; Gérald Simonneau
Journal:  Eur Respir J       Date:  2019-05-18       Impact factor: 16.671

6.  Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.

Authors:  Marta Banaszkiewicz; Arkadiusz Pietrasik; Michał Florczyk; Piotr Kędzierski; Michał Piłka; Rafał Mańczak; Janusz Kochman; Grzegorz Opolski; Adam Torbicki; Marcin Kurzyna; Szymon Darocha
Journal:  Diagnostics (Basel)       Date:  2021-01-16

Review 7.  Balloon Pulmonary Angioplasty: State of the Art.

Authors:  John G Coghlan; Alexander Mk Rothman; Stephen P Hoole
Journal:  Interv Cardiol       Date:  2021-02-15

8.  Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension in Greece: Data from the Hellenic Pulmonary Hypertension Registry.

Authors:  Panagiotis Karyofyllis; Eftychia Demerouti; George Giannakoulas; Anastasia Anthi; Alexandra Arvanitaki; George Athanassopoulos; Christos Feloukidis; Ioannis Iakovou; Theodora Kostelidou; Ioanna Mitrouska; Sophia-Anastasia Mouratoglou; Stylianos E Orfanos; Christos Pappas; Georgia Pitsiou; Eleftheria-Garyfallia Tsetika; Dimitrios Tsiapras; Vassilios Voudris; Athanassios Manginas
Journal:  J Clin Med       Date:  2022-04-15       Impact factor: 4.964

9.  Evaluation of the effect of nitric oxide inhalation in the patients with chronic thromboembolic pulmonary hypertension or pulmonary disease during balloon pulmonary angioplasty.

Authors:  Shota Saito; Nobutaka Ikeda; Raisuke Iijima; Hidehiko Hara; Masato Nakamura
Journal:  Pulm Circ       Date:  2022-01-18       Impact factor: 2.886

10.  Virtual Reality-Assisted Percutaneous Transluminal Angioplasty for Interventional Treatment of Lower-Extremity Arteriosclerosis Obliterans.

Authors:  Ruhang Zhou; Hongyan Zhai; Zhiming Yin; Jian Cui; Nan Hu
Journal:  J Healthc Eng       Date:  2021-07-27       Impact factor: 2.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.